ATH-1018

N/A

Report date: 2025/03/18 13:50:28
NME

Base Information

Drug NameATH-1018
Drug Alias NameATH-1018
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatocyte growth factor receptor modulatorsHepatocyte growth factor receptor agonists
TargetsHepatocyte growth factor receptor
Therapy Area/IndicationsDiabetic Neuropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAthira Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAthira Pharma Inc
Inactive CompaniesN/A
Active IndicationsDiabetic Neuropathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A